This evening the Progress Educational Trust will host a public event ‘Fertility Treatment Add-Ons: Do they Add Up?’, sponsored by the British Fertility Society (BFS).
Professor Adan Balen (BFS), Sally Cheshire (Chair of the Human Fertilisation and Embryology Authority), Dr Simon Fishel (CARE Fertility) and Dr Raj Mathur (St Mary’s Hospital) will all address the topic of fertility add-ons. SpermComet CEO and Chair of the British Andrology Society, Professor Sheena Lewis will also be in attendance for what proves to be an informative evening for clinicians and patients alike.
At SpermComet, we believe it is best practice to provide couples with up to date and unbiased information so they can make informed decisions about their fertility journey.
The SpermComet test provides information that the conventional semen analysis cannot. While a conventional semen analysis gives sperm count, shape and swimming speed, the SpermComet provides crucial information about the quality of the DNA that the man will pass out to his child.
The SpermComet test can also diagnose male fertility problems in couples previously told their fertility was unexplained. It can also guide to the fertility treatment best suited to that couple.
Sperm DNA testing is not new. In the last 30 years, over 1200 papers have been published on it.
The SpermComet test alone is based on 25 years of evidence-based, non-commercial academic research. The evidence-base for SpermComet was established using ART outcome data from over 500 couples.
There are no harmful side-effects to the SpermComet test as it is non-invasive. Men simply produce a semen sample which is tested at our labs by specially trained scientists. If the quality of sperm DNA is suboptimal, we can refer couples to a male fertility expert who will advise on the best short term lifestyle changes to improve the quality of their sperm DNA before undergoing any fertility treatment. Considering men contribute 50% of their baby’s genes, it’s imperative that sperm DNA is as healthy as possible. With better quality sperm DNA, each couple has a better chance of IVF success first time around. This reduces the cost of multiple IVF cycles and the heartache of failure.
Professor Adam Balen, Chair of the British Fertility Society has stated that healthcare professionals must ‘support and provide reliable information on any treatment being considered and those looking after fertility patients have their best interests at heart.’
We agree. At SpermComet, we believe couples should be offered the full picture on their fertility diagnosis before they begin their fertility journey.